Specific References (6) | SL2140R has been referenced in 6 publications.
[IF=1.48] Tang, Wei‑Jing, et al. "Role of T helper 17 cytokines in the tumour immune inflammation response of patients with laryngeal squamous cell carcinoma." Oncology Letters. IHSLCP ; Human.
[IF=1.96] Kou, Wei, et al. "Transforming growth factor-??1 promotes Treg commitment in nasal polyposis after intranasal steroid treatment."Inflammation Research (2013): 1-7.2 ELISA ; Human.
[IF=3.33] Niu, Yinghua, et al. "The balance between intrahepatic IL-17+ T cells and Foxp3+ regulatory T cells plays an important role in HBSLVrelated end-stage liver disease." BMC immunology 12.1 (2011): 47. IHSLCP ; Human.
[IF=2.868] Mangino G et al. Interleukin‐17A affects extracellular vesicles release and cargo in human keratinocytes. Exp Dermatol. 2019 Sep;28(9):1066-1073. WB ; Human.
[IF=1.39] Tang et al. Role of T helper 17 cytokines in the tumour immune inflammation response of patients with laryngeal squamous cell carcinoma. (2017) Oncol.Lett. 14:561-568 IHSLCP ; Human.
[IF=1.65] Ghazi, H. F., N. A. Mohammed, and R. J. Hussein. "Tissue IL-17A expression associated with inflammatory lesions and ATG16L1 T300A allele in Crohn’s disease." International Journal of Advanced Research 3.1 (2015): 33-40. IHSLCP ; Human.